Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: PPD 2Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: PPD 2Q

Development revenue for the quarter was $333.8 million (+1%). Discovery sciences revenue was $7.7 million, compared to $0.2 million in 2Q09.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PPD 2Q

2Q Revenues: $369.9 million (+4%)

2Q Earnings: $21.0 million (-64%)

YTD Revenues: $716.7 million (flat)

YTD Earnings: $38.2 million (-62%)

Comments: Development revenue for the quarter was $333.8 million (+1%). Discovery sciences revenue was $7.7 million, compared to $0.2 million in 2Q09. Revenue for this segment included a $7.5 million milestone payment from Takeda related to pricing approvals for Nesina (alogliptin) in Japan. Gross authorizations for the quarter totaled $610.5 million. Backlog at June 30, 2010, was $3.2 billion. Contract cancellations and adjustments were $145.3 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters